Psoriasis is a common dermatosis, affecting from 1 to 3 percent of the population. Until recently, the mainstays of topical therapy have been corticosteroids, tars, anthralins and keratolytics. Recently, however, vitamin D analogs, a new anthralin preparation and topical retinoids have expanded physicians' therapeutic armamentarium. These new topical therapies offer increased hope and convenience to the large patient population with psoriasis.
|Original language||English (US)|
|Number of pages||6|
|Journal||American Family Physician|
|State||Published - Feb 15 1999|
ASJC Scopus subject areas
- Family Practice